Exodus Point Capital Management, LP Uni Qure N.V. Transaction History

Exodus Point Capital Management, LP

$13.1 Billion
Q1 2024

A detailed history of Exodus Point Capital Management, LP transactions in Uni Qure N.V. stock. As of the latest transaction made, Exodus Point Capital Management, LP holds 116,708 shares of QURE stock, worth $448,158. This represents 0.0% of its overall portfolio holdings.

Number of Shares

116,708

Previous 45,737 155.17%

Holding current value

$448,158

Previous $307,000 97.72%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$4.82 - $6.93 $342,080 - $491,829	70,971 Added 155.17%	116,708 $607,000
Q3 2023 Nov 09, 2023	SELL	$6.71 - $11.83 $1.29 Million - $2.28 Million	-192,328 Reduced 80.79%	45,737 $307,000
Q2 2023 Aug 10, 2023	SELL	$11.12 - $22.2 $2.51 Million - $5.02 Million	-226,152 Reduced 48.72%	238,065 $2.73 Million
Q1 2023 May 11, 2023	BUY	$18.7 - $23.07 $3.22 Million - $3.98 Million	172,330 Added 59.04%	464,217 $9.35 Million
Q4 2022 Feb 13, 2023	BUY	$18.12 - $27.32 $2.21 Million - $3.34 Million	122,214 Added 72.03%	291,887 $6.62 Million

Q3 2022 Nov 10, 2022	BUY	$16.98 - $25.54 $1.36 Million - $2.04 Million	79,842 Added 88.88%	169,673 $3.18 Million
Q2 2022 Aug 19, 2022	BUY	$13.15 - $20.45 $1.18 Million - $1.84 Million	89,831 New	89,831 $1.67 Million
Q1 2022 May 13, 2022	SELL	$14.54 - $21.5 $503,621 - $744,695	-34,637 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$20.24 - $36.01 $106,199 - $188,944	5,247 Added 17.85%	34,637 $718,000
Q3 2021 Nov 15, 2021	SELL	$26.01 - $38.22 $1.31 Million - $1.93 Million	-50,420 Reduced 63.18%	29,390 $941,000
Q2 2021 Aug 16, 2021	BUY	$29.97 - $37.17 $2.04 Million - $2.53 Million	68,048 Added 578.54%	79,810 $2.46 Million
Q1 2021 May 17, 2021	SELL	$29.24 - $42.03 $240,586 - $345,822	-8,228 Reduced 41.16%	11,762 $396,000
Q4 2020 Feb 16, 2021	BUY	$35.35 - $50.67 $332,537 - $476,652	9,407 Added 88.89%	19,990 $722,000
Q3 2020 Nov 16, 2020	SELL	$35.98 - $47.66 $2.19 Million - $2.9 Million	-60,886 Reduced 85.19%	10,583 $390,000
Q2 2020 Aug 14, 2020	BUY	$45.06 - $67.74 $3.22 Million - $4.84 Million	71,469 New	71,469 $3.22 Million
Q4 2019 Feb 14, 2020	SELL	$37.13 - $74.62 $217,173 - $436,452	-5,849 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$39.36 - $76.8 $847,814 - $1.65 Million	-21,540 Reduced 78.64%	5,849 $230,000
Q2 2019 Aug 14, 2019	BUY	$52.76 - $82.19 $1.45 Million - $2.25 Million	27,389 New	27,389 $2.14 Million

Others Institutions Holding QURE

# of Institutions

148

Shares Held

34.1M

Call Options Held

1.07M

Put Options Held

603K

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $179M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Exodus Point Capital Management, LP with notifications on news.

Account

Exodus Point Capital Management, LP Uni Qure N.V. Transaction History